Johnson & Johnson MedTech launches Total Shoulder Replacement System
Palm Beaches Gardens: Johnson & Johnson MedTech has announced the U.S. launch of INHANCE INTACT, a proprietary complete instrumentation system specifically developed for subscapularis-sparing total shoulder arthroplasty (TSA), empowering surgeons to replace a damaged shoulder joint while keeping the shoulder muscle intact.
Each year, more than 100,000 Americans undergo TSA to treat degenerative conditions like osteoarthritis and rotator cuff tears. While effective, the traditional TSA deltopectoral approach often requires detachment of the subscapularis tendon, a key muscle at the front of the shoulder that has been linked to post-operative pain, instability, and tendon failure. As a result, patients often face up to six weeks of post-operative immobilization.
"The tissue-sparing approach achieved with INHANCE INTACT instrumentation allows surgeons to perform shoulder replacement procedures with enhanced joint visualization. Moreover, this approach enables patient shoulder movement as early as day one post-op. This faster rehabilitation supports the shift toward outpatient, minimally invasive care and makes INHANCE INTACT ideal for Ambulatory Surgery Centers. By reducing pain and immobilization time, the system helps patients return to work, family and daily routines sooner," the company stated in a release.
“The introduction of INHANCE INTACT marks an important step forward in advancing shoulder care through thoughtful, clinically driven innovation,” said Sharrolyn Josse, Worldwide President, Joint Reconstruction, Johnson & Johnson MedTech. “By offering solutions to surgeons that allow their patients to have immediate mobility, we’re expanding what’s possible for surgeons and strengthening an approach designed to improve outcomes, accelerate recovery, and support the shift to outpatient care.”
INHANCE INTACT is part of a comprehensive platform designed to meet the evolving demands of TSA procedures. Designed for use with the INHANCE Shoulder System, INHANCE INTACT integrates a stemless implant, 43 purpose-built instruments, and TRUMATCH Personalized Solutions to support anatomic precision, bone preservation, and surgical accuracy through patient-specific 3D planning. Together, the full procedural solution enables surgeons to deliver consistent results across a broad range of care settings.
“The INHANCE INTACT instrumentation allows surgeons to minimize or eliminate post operative subscapularis failure, a potentially devastating complication after anatomic shoulder arthroplasty,” said Dr. Paul J. Favorito, M.D., a board-certified orthopedic surgeon at The Christ Hospital.*** “The simplified approach and precise instrumentation allow anatomic prosthetic reproduction of the glenohumeral joint along with proper soft tissue balancing. This will be my preferred system for all anatomic arthroplasties.”
INHANCE INTACT is now commercially available in the U.S. The system will also be showcased at the American Shoulder and Elbow Surgeons (ASES) Annual Meeting, taking place October 15–18, 2025, in San Diego, California.
